We randomly assigned 11,140 patients with type 2 diabetes to undergo either standard glucose control or intensive glucose control, defined as the use of gliclazide (modified release) plus other drugs ...
Intensive glucose control has been suggested for critically ill patients to improve outcomes. Two recent reports, a systematic review and a new randomized trial, found this treatment was associated ...
The main findings of the ADVANCE trial included a 14% reduction in major microvascular events with intensive therapy that was primarily due to a reduction in the incidence of nephropathy (ie, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results